Search Results

Penumbra reveals positive data for algorithm-assisted thrombectomy tech

• Source: Pharma & Healthcare Monitor Worldwide (Amman, Jordan), November 8, 2024 News, 2pp

Record details

Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases; Financing led by Marshall Wace

• Authors : By:COMPANY CONTACT (888) 526-7

• Source: Business Wire, November 4, 2024, 2pp

Record details

Medtronic unveils outcomes of the largest multi-centric prospective stroke registry on mechanical thrombectomy in India (PRAAN)

• Source: Asian News International (New Delhi, India), November 7, 2024 News, 5pp

Record details

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

• Source: PR Newswire (USA), November 5, 2024, 4pp

Record details

Akura Medical's application for trial of Katana Thrombectomy System receives US FDA approval

• Source: M2 Pharma (England), November 5, 2024 News, 1pp

Record details

Vesalio Announces Launch of pVasc Study in the U.S. While featuring the pVasc Thrombectomy System at VIVA, VEITH, and TCT

• Source: ENP Newswire (UK), October 28, 2024 News, 2pp

Record details

Vesalio Announces Clinical Study Initiative for the Recently Launched pVasc Thrombectomy System and Planned Attendance at TCT, VIVA, and VEITH Meetings

• Source: PR Newswire (USA), October 25, 2024, 2pp

Record details

TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability

• Source: PR Newswire (USA), October 25, 2024, 2pp

Record details

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with PounceT Thrombectomy System; Early subset analysis of 60 patients with acute, subacute, or chronic symptoms of limb ischemia demonstrated 96.8% procedural flow restoration, with 81.7% of subjects not receiving additional thromboemboli removal treatment post PounceT System use.

• Authors : By:Surmodics Investor Inquiries: Jack Powell, Investo

• Source: Business Wire, October 30, 2024, 4pp

Record details

USPTO ISSUES TRADEMARK: LAGUNA THROMBECTOMY SYSTEM

• Source: US Fed News (USA), October 31, 2024, 1pp

Record details